These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 831455)

  • 1. Normotest--thrombotest discrepancy in congenital coagulation disorders of the prothrombin complex and in coumarin-treated patients: a nonspecific phenomenon.
    Girolami A; Brunetti A; Patrassi GM
    Am J Clin Pathol; 1977 Jan; 67(1):57-60. PubMed ID: 831455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombotest mixing experiments in congenital coagulation disorders of the prothrombin complex and in coumarin treated patients. An additional evidence against the presence of an inhibitor in the latter.
    Girolami A; Patrassi O; Cella G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1977; 104(3):463-70. PubMed ID: 72033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glass activation-induced decrease or disappearance of normotest-thrombotest discrepancy in congenital coagulation disorders of the prothrombin complex.
    Girolami A; Patrassi G; Fabris F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1977; 104(2):283-93. PubMed ID: 69593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decrease of normotest/thrombotest discrepancy in non-contacted coumarin plasma after glass or ellagic acid activation.
    Girolami A; Patrassi G; Burul A
    Blut; 1976 Jul; 33(1):41-8. PubMed ID: 974273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitor of human blood coagulation elicited by thrombin.
    Marciniak E
    J Lab Clin Med; 1972 Jun; 79(6):924-34. PubMed ID: 5025460
    [No Abstract]   [Full Text] [Related]  

  • 6. AN INVESTIGATION OF THE HEMORRHAGIC DIATHESIS IN PATIENTS RECEIVING COUMARIN AND INDANEDIONE ANTICOAGULANTS.
    BAUGH CW
    Can Med Assoc J; 1965 Jan; 92(3):116-20. PubMed ID: 14232183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Quick's time and derived times in the study of the extrinsic course of the coagulation process. The PIVKA (protein induced by vitamin K absence or antagonists) in states of chronic disseminated intravascular coagulation].
    Moscarella S; Ventimiglia V
    Quad Sclavo Diagn; 1974 Dec; 10(4):463-73. PubMed ID: 4460075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromogenic substrate (S-2238) prothrombin assay in prothrombin deficiencies and abnormalities. Lack of identity with clotting assays in congenital dysprothrombinemias.
    Girolami A; Patrassi G; Toffanin F; Saggin L
    Am J Clin Pathol; 1980 Jul; 74(1):83-7. PubMed ID: 7395819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological properties of the thromboplastins and plasmas included in the ICTH/ICSH collaborative study on prothrombin time standardization.
    Loeliger EA; van Halem-Visser LP
    Thromb Haemost; 1979 Dec; 42(4):1115-27. PubMed ID: 542924
    [No Abstract]   [Full Text] [Related]  

  • 10. [Statistical comparison between prothrombin time, Owren's thrombotest and cephalin time during the surveillance of anticoagulant therapy].
    Aznar J; Fernández Pavón A; Aznar JA
    Sangre (Barc); 1972; 17(2):187-92. PubMed ID: 5035457
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hepato-quick--a new thromboplastin time system: a comparison with normotest and thrombotest (author's transl)].
    Fischer M; Falkensammer C
    Wien Klin Wochenschr; 1974 Oct; 86(19):577-83. PubMed ID: 4432516
    [No Abstract]   [Full Text] [Related]  

  • 12. Factor X assays using chromogenic substrate S-2222.
    Girolami A; Saggin L; Boeri G
    Am J Clin Pathol; 1980 Mar; 73(3):400-2. PubMed ID: 7361721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prothrombin utilization in congenital coagulation deficiency states.
    Owen CA; Thompson JH
    Thromb Diath Haemorrh; 1971 Jun; 25(2):297-311. PubMed ID: 5568049
    [No Abstract]   [Full Text] [Related]  

  • 14. The procoagulant activity of granulocytes.
    Saba HI; Herion JC; Walker RI; Roberts HR
    Proc Soc Exp Biol Med; 1973 Feb; 142(2):614-20. PubMed ID: 4689394
    [No Abstract]   [Full Text] [Related]  

  • 15. Improved coagulation in bleeding disorders by Non-Anticoagulant Sulfated Polysaccharides (NASP).
    Liu T; Scallan CD; Broze GJ; Patarroyo-White S; Pierce GF; Johnson KW
    Thromb Haemost; 2006 Jan; 95(1):68-76. PubMed ID: 16543964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Congenital deficiency of vitamin K-dependent coagulation factors and protein C.
    Vicente V; Maia R; Alberca I; Tamagnini GP; Lopez Borrasca A
    Thromb Haemost; 1984 Jul; 51(3):343-6. PubMed ID: 6548583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Checking oral anticoagulation in capillary blood].
    Navarro JL; César JM; García Frade LJ; Pardo A; Avello AG; Trejo R; Villarrubia J; López J
    Sangre (Barc); 1994 Aug; 39(4):257-60. PubMed ID: 7985054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet aggregation and adhesiveness in classical factor X deficiency and in the abnormal factor X (factor X Friuli) coagulation disorder.
    Girolami A; Fabris F; Peruffo R; Coser P
    Acta Haematol; 1976; 56(5):307-13. PubMed ID: 826088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The K-test (trypsin clotting time) in coumarin treated patients and in congenital deficiencies and abnormalities of the prothrombin complex.
    Girolami A; Brunetti A; Patrassi G; Cafiero F
    Blut; 1975 Nov; 31(5):291-8. PubMed ID: 811288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apparent "inhibition" as tested by means of the dilution curve system in patients with clotting defect due to liver damage.
    Girolami A; Dal Bo Zanon R; Sticchi A
    Blut; 1977 Sep; 35(3):247-52. PubMed ID: 912109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.